| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Common Stock | Options Exercise | $0 | +2,863 | +18% | $0.000000 | 18,972 | 31 Mar 2024 | Direct | |
| transaction | OGN | Common Stock | Tax liability | $18,443 | -981 | -5.2% | $18.80 | 17,991 | 31 Mar 2024 | Direct | |
| transaction | OGN | Common Stock | Options Exercise | $0 | +4,606 | +26% | $0.000000 | 22,597 | 31 Mar 2024 | Direct | |
| transaction | OGN | Common Stock | Tax liability | $29,666 | -1,578 | -7% | $18.80 | 21,019 | 31 Mar 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -2,863 | -50% | $0.000000 | 2,863 | 31 Mar 2024 | Common Stock | 2,863 | Direct | F1, F2 | |
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -4,606 | -33% | $0.000000 | 9,212 | 31 Mar 2024 | Common Stock | 4,606 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. |
| F2 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025. |
| F3 | The Reporting Person was granted RSUs on March 31, 2023. On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026. |